Spots Global Cancer Trial Database for Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM
Official Title: An External Control, Observational, Retrospective Study Assessing the Effect of Avapritinib Compared With Best Available Therapy for Patients With Advanced Systemic Mastocytosis
Study ID: NCT04695431
Interventions
Study Description
Brief Summary: BLU-285-2405 is a multi-center, synthetic control, observational and retrospective study designed to compare clinical outcomes for avapritinib compared with best available therapy for patients with AdvSM.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Standford Cancer Center, Palo Alto, California, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Medizinische Universitat Wien, Vienna, , Austria
Universitatmedizin Mannheim, Mannheim, Baden-Württemberg, Germany
Hospital Virgen del Valle, Toledo, , Spain
Guy's and St. Thomas' NHS Foundation Trust, London, England, United Kingdom
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
